85 related articles for article (PubMed ID: 38432118)
21. Pipeline of anti-Mycobacterium abscessus small molecules: Repurposable drugs and promising novel chemical entities.
Egorova A; Jackson M; Gavrilyuk V; Makarov V
Med Res Rev; 2021 Jul; 41(4):2350-2387. PubMed ID: 33645845
[TBL] [Abstract][Full Text] [Related]
22. Thiopeptides Induce Proteasome-Independent Activation of Cellular Mitophagy.
Bird KE; Xander C; Murcia S; Schmalstig AA; Wang X; Emanuele MJ; Braunstein M; Bowers AA
ACS Chem Biol; 2020 Aug; 15(8):2164-2174. PubMed ID: 32589399
[TBL] [Abstract][Full Text] [Related]
23. Molecule Property Analyses of Active Compounds for
Makarov V; Salina E; Reynolds RC; Kyaw Zin PP; Ekins S
J Med Chem; 2020 Sep; 63(17):8917-8955. PubMed ID: 32259446
[TBL] [Abstract][Full Text] [Related]
24. ROBOKOP KG and KGB: Integrated Knowledge Graphs from Federated Sources.
Bizon C; Cox S; Balhoff J; Kebede Y; Wang P; Morton K; Fecho K; Tropsha A
J Chem Inf Model; 2019 Dec; 59(12):4968-4973. PubMed ID: 31769676
[TBL] [Abstract][Full Text] [Related]
25. The neXtProt knowledgebase in 2020: data, tools and usability improvements.
Zahn-Zabal M; Michel PA; Gateau A; Nikitin F; Schaeffer M; Audot E; Gaudet P; Duek PD; Teixeira D; Rech de Laval V; Samarasinghe K; Bairoch A; Lane L
Nucleic Acids Res; 2020 Jan; 48(D1):D328-D334. PubMed ID: 31724716
[TBL] [Abstract][Full Text] [Related]
26. The DisGeNET knowledge platform for disease genomics: 2019 update.
Piñero J; Ramírez-Anguita JM; Saüch-Pitarch J; Ronzano F; Centeno E; Sanz F; Furlong LI
Nucleic Acids Res; 2020 Jan; 48(D1):D845-D855. PubMed ID: 31680165
[TBL] [Abstract][Full Text] [Related]
27. Why Wait? The Case for Treating Tuberculosis with Inhaled Drugs.
Braunstein M; Hickey AJ; Ekins S
Pharm Res; 2019 Oct; 36(12):166. PubMed ID: 31650321
[TBL] [Abstract][Full Text] [Related]
28. Identification of New MmpL3 Inhibitors by Untargeted and Targeted Mutant Screens Defines MmpL3 Domains with Differential Resistance.
Williams JT; Haiderer ER; Coulson GB; Conner KN; Ellsworth E; Chen C; Alvarez-Cabrera N; Li W; Jackson M; Dick T; Abramovitch RB
Antimicrob Agents Chemother; 2019 Oct; 63(10):. PubMed ID: 31405862
[TBL] [Abstract][Full Text] [Related]
29. Repurposing Approved Drugs as Inhibitors of K
Ekins S; Gerlach J; Zorn KM; Antonio BM; Lin Z; Gerlach A
Pharm Res; 2019 Jul; 36(9):137. PubMed ID: 31332533
[TBL] [Abstract][Full Text] [Related]
30. Repositioning rifamycins for Mycobacterium abscessus lung disease.
Ganapathy US; Dartois V; Dick T
Expert Opin Drug Discov; 2019 Sep; 14(9):867-878. PubMed ID: 31195849
[No Abstract] [Full Text] [Related]
31. Dual activity of niclosamide to suppress replication of integrated HIV-1 and Mycobacterium tuberculosis (Beijing).
Fan X; Xu J; Files M; Cirillo JD; Endsley JJ; Zhou J; Endsley MA
Tuberculosis (Edinb); 2019 May; 116S():S28-S33. PubMed ID: 31080089
[TBL] [Abstract][Full Text] [Related]
32.
Lopeman RC; Harrison J; Desai M; Cox JAG
Microorganisms; 2019 Mar; 7(3):. PubMed ID: 30909391
[TBL] [Abstract][Full Text] [Related]
33. New drugs to treat difficult tuberculous and nontuberculous mycobacterial pulmonary disease.
Lee SFK; Laughon BE; McHugh TD; Lipman M
Curr Opin Pulm Med; 2019 May; 25(3):271-280. PubMed ID: 30865034
[TBL] [Abstract][Full Text] [Related]
34. Multiple Machine Learning Comparisons of HIV Cell-based and Reverse Transcriptase Data Sets.
Zorn KM; Lane TR; Russo DP; Clark AM; Makarov V; Ekins S
Mol Pharm; 2019 Apr; 16(4):1620-1632. PubMed ID: 30779585
[TBL] [Abstract][Full Text] [Related]
35. High Throughput and Computational Repurposing for Neglected Diseases.
Hernandez HW; Soeung M; Zorn KM; Ashoura N; Mottin M; Andrade CH; Caffrey CR; de Siqueira-Neto JL; Ekins S
Pharm Res; 2018 Dec; 36(2):27. PubMed ID: 30560386
[TBL] [Abstract][Full Text] [Related]
36. Novel Screen to Assess Bactericidal Activity of Compounds Against Non-replicating
Berube BJ; Castro L; Russell D; Ovechkina Y; Parish T
Front Microbiol; 2018; 9():2417. PubMed ID: 30364170
[No Abstract] [Full Text] [Related]
37. The EU approved antimalarial pyronaridine shows antitubercular activity and synergy with rifampicin, targeting RNA polymerase.
Mori G; Orena BS; Franch C; Mitchenall LA; Godbole AA; Rodrigues L; Aguilar-Pérez C; Zemanová J; Huszár S; Forbak M; Lane TR; Sabbah M; Deboosere N; Frita R; Vandeputte A; Hoffmann E; Russo R; Connell N; Veilleux C; Jha RK; Kumar P; Freundlich JS; Brodin P; Aínsa JA; Nagaraja V; Maxwell A; Mikušová K; Pasca MR; Ekins S
Tuberculosis (Edinb); 2018 Sep; 112():98-109. PubMed ID: 30205975
[TBL] [Abstract][Full Text] [Related]
38. Comparing and Validating Machine Learning Models for Mycobacterium tuberculosis Drug Discovery.
Lane T; Russo DP; Zorn KM; Clark AM; Korotcov A; Tkachenko V; Reynolds RC; Perryman AL; Freundlich JS; Ekins S
Mol Pharm; 2018 Oct; 15(10):4346-4360. PubMed ID: 29672063
[TBL] [Abstract][Full Text] [Related]
39. UniProt: the universal protein knowledgebase.
UniProt Consortium T
Nucleic Acids Res; 2018 Mar; 46(5):2699. PubMed ID: 29425356
[No Abstract] [Full Text] [Related]
40. DrugBank 5.0: a major update to the DrugBank database for 2018.
Wishart DS; Feunang YD; Guo AC; Lo EJ; Marcu A; Grant JR; Sajed T; Johnson D; Li C; Sayeeda Z; Assempour N; Iynkkaran I; Liu Y; Maciejewski A; Gale N; Wilson A; Chin L; Cummings R; Le D; Pon A; Knox C; Wilson M
Nucleic Acids Res; 2018 Jan; 46(D1):D1074-D1082. PubMed ID: 29126136
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
